Revenue Soars 62 Percent, German Pharmaceutical Company Earns IDR 132 Billion Profit In 2021

JAKARTA – The German pharmaceutical science and technology company PT Merck Tbk (MERK) recorded revenue of IDR 1 trillion throughout 2021. The score rose 62 percent year on year (YoY) compared to 2021 which was IDR 656 billion.

President Director of Merck Evie Yulin said the increase in revenue was offset by improved operational efficiency within the company. "This result also boosted the company's net profit with a growth of 83 percent YoY to IDR 132 billion last year", he said when giving a press statement to reporters via virtual channels on Wednesday, May 25.

According to Evie, based on this note, the annual general meeting of shareholders (AGM) agreed that the company would distribute a final dividend for the 2021 financial year in the amount of IDR 107.5 billion.

"This final dividend is equivalent to IDR 240 per share", he said.

In detail, Evie explained that the company's total assets, liabilities, and equity for the 2021 period were recorded at IDR 1 trillion, IDR 342 billion, and IDR 684 billion, respectively, with growths of 10 percent, 8 percent, and 12 percent compared to the previous year.

Meanwhile, the current ratio was 2.71, liabilities to equity 0.50, and liabilities to assets 0.33. profitability ratio was maintained with a gross profit margin of 37.46 percent, ROA rose to 12.83 percent from 7.73 percent and ROE rose to 19.25 percent from 11.74 percent.